RDY: Dr. Reddy`s Laboratories Ltd. - ADR Company Profile & Statistics

About

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.

Info & Links

CEO

Erez Israeli

Headquarters

8-2-337, ROAD NO.3 BANJARA HILLS
HYDERABAD, K7 500-034, INDIA

Auditor

Ernst & Young Associates LLP

Share holders

Employees

27,048

Dr. Reddy`s Laboratories Ltd. - ADR Statistics

Valuation Measures

Market Capitalization²

12.08B

Enterprise Value

12.53B

Enterprise Value/EBITDA(ttm)

12.68

Price to Earnings Ratio(ttm)

23.10

Price to Sales(ttm)

3.36

Price to Book(mrq)

3.27

Price to Cash(ytd)

14.26

Profitability

Gross Margin(ttm)

59.24%

Operating Margin(ttm)

17.81%

Profit Margin(ttm)

17.82%

Return on Equity(ttm)

18.53%

Return on Invested Capital(ttm)

18.33%

Return on Assets(ttm)

13.01%

Income Statement

Revenue(ttm)

3.58B

Revenue Per Share(ttm)

Gross Profit(ttm)

2.12B

EBITDA(ttm)³

987.80M

Net Income Available to Common(ttm)

635.24M

Diluted EPS(ttm)

0.63

Share Statistics

Beta (5Y Monthly)

0.53

52-Week Change

4.25%

S&P 500 52-Week Change

27.63%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.56%

Float⁴

818.03M

% Held by Insiders

2.00%

% Held by Institutions

3.85%

Balance Sheet

Total Cash(mrq)

758.00M

Total Cash Per Share(mrq)

Total Debt(mrq)

580.00M

Total Debt/Equity(mrq)

15.71%

Current Ratio(mrq)

1.92%

Quick Ratio(mrq)

1.36%

Book Value Per Share(mrq)

0.89

Cash Flow

Operating Cash Flow Per Share(ytd)

0.05

Free Cash Flow(ytd)

66.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RDY

Dr. Reddy`s Laboratories Ltd. - ADR

Dr. Reddy`s Laboratories Ltd. - ADR Profile